The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration
Open accessAbstract
There has been growing interest in the use of retinal imaging for tracking disease progression in multiple sclerosis. However, systematic and detailed pathological descriptions of retinal tissue in multiple sclerosis are lacking. Graded, histological evaluations on eyes from 82 patients with multiple sclerosis and 10 subjects with other neurological diseases, with immunohistochemistry on a subset, were performed and correlated with clinical and pathological findings. Multiple sclerosis cases demonstrated evidence of retinal atrophy and inflammation even in late-stage disease. Retinal ganglion cell loss was significant and remaining neurons appeared shrunken and were partially engulfed by human leukocyte antigen-DR positive cells with the phenotype of microglia in samples subjected to immunohistochemistry. Neurofilament staining revealed variable but prominent degrees of axonal loss and injury. Neuronal loss was noted in the inner nuclear layer with focal reduction in cell density. Foamy-appearing human leukocyte antigen-DR positive cells were evident near vessels and periphlebitis was found in a small but significant number of multiple sclerosis cases. Glial fibrillary acidic protein staining showed extensive astrocyte hypertrophy and proliferation with prominent gliosis in multiple sclerosis cases. Frequent but previously unreported abnormalities in the iris were documented in the majority of chronic multiple sclerosis cases. The injury to both iris and retina could be seen at all stages of disease. Severity of retinal atrophy was correlated with overall brain weight at time of autopsy (P = 0.04) and a trend for increased atrophy was seen with longer disease duration (P = 0.13). This study provides the first large-scale pathological description of retinas in multiple sclerosis, including patients with different subtypes of disease at all stages, and with variable clinical severity. Changes were seen not only in the retinal nerve fibre layer and ganglion cell layer, but also in the inner nuclear layer, suggesting that retinal injury is more widespread than previously appreciated. Furthermore, the human retina is devoid of myelin, but inflammation was demonstrated to be prominent in multiple sclerosis and to persist in the retina at late stages of disease. The prominent gliosis and inflammation surrounding vessels of the inner retina could potentially impact optical coherence tomography evaluations in multiple sclerosis-as standard techniques exploit presumed differences in tissue reflectivity and utilize automated edge detection algorithms to judge axon loss in the nerve fibre layer. Deciphering the relationships between the different types of retinal pathology may aid us in understanding the factors that drive both inflammation and tissue atrophy in multiple sclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., Johnson, K. P., Sibley, W. A., Silberberg, D. H., & Tourtellotte, W. W. (1983) · Annals of Neurology · doi:10.1002/ana.410130302 · Cited by 7,384
Rao, S. V., & Jollis, J. G. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.10.991 · Cited by 2,217
Cortical demyelination and diffuse white matter injury in multiple sclerosis
Kutzelnigg, A., Lucchinetti, C. F., Stadelmann, C., Brück, W., Rauschka, H., Bergmann, M., Schmidbauer, M., Parisi, J. E., & Lassmann, H. (2005) · Brain · doi:10.1093/brain/awh641 · Cited by 1,836
Relation of Visual Function to Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis
FISHER, J., JACOBS, D., MARKOWITZ, C., GALETTA, S., VOLPE, N., NANOSCHIAVI, M., BAIER, M., FROHMAN, E., WINSLOW, H., & FROHMAN, T. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2005.10.040 · Cited by 658
Quantifying axonal loss after optic neuritis with optical coherence tomography
Costello, F., Coupland, S., Hodge, W., Lorello, G. R., Koroluk, J., Pan, Y. I., Freedman, M. S., Zackon, D. H., & Kardon, R. H. (2006) · Annals of Neurology · doi:10.1002/ana.20851 · Cited by 610
Brück, W., Bitsch, A., Kolenda, H., Brück, Y., Stiefel, M., & Lassmann, H. (1997) · Annals of Neurology · doi:10.1002/ana.410420515 · Cited by 519
Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis
Trip, S. A., Schlottmann, P. G., Jones, S. J., Altmann, D. R., Garway-Heath, D. F., Thompson, A. J., Plant, G. T., & Miller, D. H. (2005) · Annals of Neurology · doi:10.1002/ana.20575 · Cited by 509
Multiple Sclerosis Risk After Optic Neuritis: Final Optic Neuritis Treatment Trial Follow-up
(2008) · Archives of Neurology · doi:10.1001/archneur.65.6.727 · Cited by 476
Glaucoma as a neurodegenerative disease
Gupta, N., & Yücel, Y. H. (2007) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e3280895aea · Cited by 422
Correlation between morphological and functional retinal impairment in multiple sclerosis patients.
Parisi, V., Manni, G., Spadaro, M., Colacino, G., Restuccia, R., Marchi, S., Bucci, M. G., & Pierelli, F. (1999) · PubMed · Cited by 420
Balcer, L. J. (2006) · New England Journal of Medicine · doi:10.1056/nejmcp053247 · Cited by 390
THE NEUROPATHOLOGY OF MULTIPLE SCLEROSIS
Ludwin, S. K. (2000) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(25)00665-3 · Cited by 329
Evangelou, N. (2001) · Brain · doi:10.1093/brain/124.9.1813 · Cited by 323
Correlation between morphological and functional retinal impairment in multiple sclerosis patients
Sacco, R., Servillo, G., Dinacci, D., Bonavita, S., Lavornia, L., Gallo, A., Ammendola, A., Lanza, M., Costanzo, A. D., Rosa, N., et al. (2007) · Cited by 323
Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS
Sepulcre, J., Murie-Fernandez, M., Salinas-Alaman, A., García-Layana, A., Bejarano, B., & Villoslada, P. (2007) · Neurology · doi:10.1212/01.wnl.0000260612.51849.ed · Cited by 298
Retrograde trans-synaptic retinal ganglion cell loss identified by optical coherence tomography
Jindahra, P., Petrie, A., & Plant, G. T. (2009) · Brain · doi:10.1093/brain/awp001 · Cited by 268
Investigative Ophthalmology & Visual Science
(2024) · doi:10.70706/iovs · Cited by 265
YOUL, B. D., TURANO, G., MILLER, D. H., TOWELL, A. D., MACMANUS, D. G., MOORE, S. G., JONES, S. J., BARRETT, G., KENDALL, B. E., MOSELEY, I. F., et al. (1991) · Brain · doi:10.1093/brain/114.6.2437 · Cited by 259
Henderson, A. P. D., Trip, S. A., Schlottmann, P. G., Altmann, D. R., Garway-Heath, D. F., Plant, G. T., & Miller, D. H. (2007) · Brain · doi:10.1093/brain/awm285 · Cited by 239
Evolving Management of Optic Neuritis and Multiple Sclerosis
Arnold, A. C. (2005) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.01.031 · Cited by 175
RETINAL PATHOLOGIC CHANGES IN MULTIPLE SCLEROSIS
KERRISON, J. B., FLYNN, T., & GREEN, W. R. (1994) · Retina · doi:10.1097/00006982-199414050-00010 · Cited by 173
Krishnamoorthy, G., Saxena, A., Mars, L., Domingues, H., Mentele, R., ben-Nun, A., Lassmann, H., Dornmair, K., Kurschus, F., Liblau, R., et al. (2009) · Nature Medicine · doi:10.1038/nm.1975 · Cited by 170
Mechanisms and Time Course of Neuronal Degeneration in Experimental Autoimmune Encephalomyelitis
Hobom, M., Storch, M. K., Weissert, R., Maier, K., Radhakrishnan, A., Kramer, B., Bähr, M., & Diem, R. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00047.x · Cited by 158
Shindler, K. S., Ventura, E. S., Dutt, M., & Rostami, A. M. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.05.017 · Cited by 153
The topography of plaques in multiple sclerosis with special reference to cerebral plaques.
Fog, T. (1965) · PubMed · Cited by 128
Mháille, A. N., McQuaid, S., Windebank, A., Cunnea, P., McMahon, J., Samali, A., & FitzGerald, U. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318165b239 · Cited by 128
Self-citationToussaïnt, D., Périer, O., Verstappen, A., & Bervoets, S. (1983) · PubMed · Cited by 122
Retinal Periphlebitis and Retinitis in Multiple Sclerosis
Arnold, A. C., Pepose, J. S., Hepler, R. S., & Foos, R. Y. (1984) · Ophthalmology · doi:10.1016/s0161-6420(84)34296-8 · Cited by 113
SHEATHING OF THE RETINAL VEINS IN MULTIPLE SCLEROSIS
RUCKER, W. (1945) · JAMA · doi:10.1001/jama.1945.02860150014003 · Cited by 96
Recovery from optic neuritis: an ROI-based analysis of LGN and visual cortical areas
Korsholm, K., Madsen, K. H., Frederiksen, J. L., Skimminge, A., & Lund, T. E. (2007) · Brain · doi:10.1093/brain/awm045 · Cited by 96
Balcer, L. J. (2001) · Current Treatment Options in Neurology · doi:10.1007/s11940-001-0043-4 · Cited by 92
Evans, J. R., Fletcher, A. E., & Wormald, R. (2004) · Ophthalmology · doi:10.1016/j.ophtha.2003.07.012 · Cited by 83
Ocular inflammatory changes in established multiple sclerosis.
GRAHAM, E. M., Francis, D. A., Sanders, M. D., et al. (1989) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.12.1360 · Cited by 61
Retinal nerve fibre layer imaging compared with histological measurements in a human eye
Blumenthal, E. Z., Parikh, R. S., Pe'er, J., et al. (2007) · Eye · doi:10.1038/sj.eye.6702942 · Cited by 58
Schmidt, S., Wessels, L., Augustin, A. J., & Klockgether, T. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00520-2 · Cited by 53
Retinal Venous Sheathing and the Blood-Retinal Barrier in Multiple Sclerosis
Birch, M., Barbosa, S., Blumhardt, L. D., O'Brien, C., & Harding, S. P. (1996) · Archives of Ophthalmology · doi:10.1001/archopht.1996.01100130032005 · Cited by 51
Electroretinographic abnormalities in multiple sclerosis: possible role for retinal autoantibodies
Forooghian, F., Sproule, M., Westall, C. A., Gordon, L. K., Jirawuthiworavong, G. V., Shimazaki, K., & O'Connor, P. W. (2006) · Documenta Ophthalmologica · doi:10.1007/s10633-006-9022-0 · Cited by 49
Localization and characterization of immunocompetent cells in the human retina
Yang, P., Das, P. K., & Kijlstra, A. (2000) · Ocular Immunology and Inflammation · doi:10.1076/0927-3948(200009)831-kft149 · Cited by 49
Retinal arteritis, retinal vasculitis and autoimmune retinal vasculitis
Sanders, M. D. (1987) · Eye · doi:10.1038/eye.1987.68 · Cited by 47
Prevalence of primary open angle glaucoma in general ophthalmic practice in the United Kingdom
Kroese, M. (2002) · British Journal of Ophthalmology · doi:10.1136/bjo.86.9.978 · Cited by 37
Sperfeld (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199911)46:5 · Cited by 2
Cited by
Reich, D. S., Lucchinetti, C. F., & Calabresi, P. A. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1401483 · Cited by 2,491
Optical coherence tomography angiography
Spaide, R. F., Fujimoto, J. G., Waheed, N. K., Sadda, S. R., & Staurenghi, G. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.11.003 · Cited by 1,779
Filippi, M., Bar-Or, A., Piehl, F., Preziosa, P., Solari, A., Vukusic, S., & Rocca, M. A. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0041-4 · Cited by 1,562
The retina as a window to the brain—from eye research to CNS disorders
London, A., Benhar, I., & Schwartz, M. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.227 · Cited by 1,403
The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment
Tewarie, P., Balk, L., Costello, F., Green, A., Martin, R., Schippling, S., & Petzold, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034823 · Cited by 627
Self-citation
Metadata
- Authors
- Green, A. J., McQuaid, S., Hauser, S. L., Allen, I. V., & Lyness, R.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-04-21
- Volume
- 133
- Issue
- 6
- Pages
- 1591-1601
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2057911576
- Cited by
- 487
- References
- 41
- FWCI
- 17.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.